v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue $ 16,098 $ 10,680
Cost of sales 4,705 3,643
Gross profit 11,393 7,037
Operating expenses    
Research and development 20,596 16,965
Selling, general and administrative 32,051 23,134
Total operating expenses 52,647 40,099
Operating loss 41,254 33,062
Other (income) expenses    
Net finance (income) expense (1,070) (1,436)
Net foreign exchange (gain) loss 2,134 (3,808)
Total other (income) expenses 1,064 (5,244)
Net loss before income taxes 42,318 27,818
Income tax expense (note 13) 231 144
Deferred tax (recovery) expense (note 13) 21 (146)
Total income tax (recovery) expense 252 (2)
Net loss attributed to shareholders for the year 42,570 27,816
Item that may be reclassified to (income) loss    
Foreign currency translation adjustment (2,283) 2,823
Net loss and other comprehensive loss for the year $ 40,287 $ 30,639
Loss per share (note 14)    
Basic net loss per common share (in dollars per share) $ 1.41 $ 1.12
Diluted net loss per common share (in dollars per share) $ 1.41 $ 1.12
Basic weighted average common shares outstanding (in shares) 30,232,966 24,765,503
Diluted weighted average common shares outstanding (in shares) 30,232,966 24,765,503
Recurring - non-capital    
Revenue $ 9,730 $ 8,240
Capital equipment    
Revenue $ 6,368 $ 2,440

Source